Catalyst Wire Dossier Catalyst Wire Dossier

Melphalan (brand Alkeran)

melphalan
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Melphalan (brand Alkeran), covering 2011-05-16 to 2011-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant [Phase 1, Phase 2]

See pricing